Same Indication

Nivolumab vs Pravastatin

Nivolumab vs Pravastatin: Overview

This comparison examines the pharmacological differences between Nivolumab and Pravastatin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pravastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Pravastatin β€” 1.8 hours.

Chemical Properties

Molecular Formula: Pravastatin β€” C23H36O7.

Molecular Weight: Pravastatin β€” 424.5280 g/mol.

Type: Nivolumab β€” Antibody; Pravastatin β€” Small molecule.